Literature DB >> 18634022

Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.

M Mitui1, S A Nahas, L T Du, Z Yang, C H Lai, K Nakamura, S Arroyo, S Scott, A Purayidom, P Concannon, M Lavin, R A Gatti.   

Abstract

The functional consequences of missense variants are often difficult to predict. This becomes especially relevant when DNA sequence changes are used to determine a diagnosis or prognosis. To analyze the consequences of 12 missense variants in patients with mild forms of ataxia-telangiectasia (A-T), we employed site-directed mutagenesis of ataxia-telangiectasia mutated (ATM) cDNA followed by stable transfections into a single A-T cell line to isolate the effects of each allele on the cellular phenotype. After induction of the transfected cells with CdCl2, we monitored for successful ATM transcription and subsequently assessed: 1) intracellular ATM protein levels; 2) ionizing radiation (IR)-induced ATM kinase activity; and 3) cellular radiosensitivity. We then calculated SIFT and PolyPhen scores for the missense changes. Nine variants produced little or no correction of the A-T cellular phenotype and were interpreted to be ATM mutations; SIFT/PolyPhen scores supported this. Three variants corrected the cellular phenotype, suggesting that they represented benign variants or polymorphisms. SIFT and PolyPhen scores supported the functional analyses for one of these variants (c.1709T>C); the other two were predicted to be "not tolerated" (c.6188G>A and c.6325T>G) and were classified as "operationally neutral." Genotype/phenotype relationships were compared: three deleterious missense variants were associated with an increased risk of cancer (c.6679C>T, c.7271T>G, and c.8494C>T). In situ mutagenesis represents an effective experimental approach for distinguishing deleterious missense mutations from benign or operationally neutral missense variants. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18634022      PMCID: PMC2776735          DOI: 10.1002/humu.20805

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  81 in total

Review 1.  PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways.

Authors:  Robert T Abraham
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

2.  Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation.

Authors:  Ambereen Ali; Ji Zhang; Shideng Bao; Irene Liu; Diane Otterness; Nicholas M Dean; Robert T Abraham; Xiao-Fan Wang
Journal:  Genes Dev       Date:  2004-02-01       Impact factor: 11.361

3.  Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression.

Authors:  Helen H Chun; Xia Sun; Shareef A Nahas; Sharon Teraoka; Chih Hung Lai; Patrick Concannon; Richard A Gatti
Journal:  Mol Genet Metab       Date:  2003-12       Impact factor: 4.797

Review 4.  Ataxia-telangiectasia: diagnosis and treatment.

Authors:  Susan Perlman; Sara Becker-Catania; Richard A Gatti
Journal:  Semin Pediatr Neurol       Date:  2003-09       Impact factor: 1.636

5.  ATM missense mutations are frequent in patients with breast cancer.

Authors:  Steve S Sommer; Zefei Jiang; Jinong Feng; Carolyn H Buzin; Jian Zheng; Jeffrey Longmate; Mira Jung; Jefferson Moulds; Anatoly Dritschilo
Journal:  Cancer Genet Cytogenet       Date:  2003-09

6.  Immunodeficiency and infections in ataxia-telangiectasia.

Authors:  Anna Nowak-Wegrzyn; Thomas O Crawford; Jerry A Winkelstein; Kathryn A Carson; Howard M Lederman
Journal:  J Pediatr       Date:  2004-04       Impact factor: 4.406

7.  ESEfinder: A web resource to identify exonic splicing enhancers.

Authors:  Luca Cartegni; Jinhua Wang; Zhengwei Zhu; Michael Q Zhang; Adrian R Krainer
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

8.  Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths.

Authors:  Laura Eng; Gabriela Coutinho; Shareef Nahas; Gene Yeo; Robert Tanouye; Mahnoush Babaei; Thilo Dörk; Christopher Burge; Richard A Gatti
Journal:  Hum Mutat       Date:  2004-01       Impact factor: 4.878

9.  Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study.

Authors:  Rulla M Tamimi; Susan E Hankinson; Donna Spiegelman; Peter Kraft; Graham A Colditz; David J Hunter
Journal:  Breast Cancer Res       Date:  2004-06-04       Impact factor: 6.466

10.  ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer.

Authors:  J L Bernstein; L Bernstein; W D Thompson; C F Lynch; K E Malone; S L Teitelbaum; J H Olsen; H Anton-Culver; J D Boice; B S Rosenstein; A-L Børresen-Dale; R A Gatti; P Concannon; R W Haile
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640

View more
  28 in total

1.  Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.

Authors:  Virginie Jacquemin; Guillaume Rieunier; Sandrine Jacob; Dorine Bellanger; Catherine Dubois d'Enghien; Anthony Laugé; Dominique Stoppa-Lyonnet; Marc-Henri Stern
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

2.  Homozygosity for c 6325T>G transition in the ATM gene causes an atypical, late-onset variant form of ataxia-telangiectasia.

Authors:  Gabriella Silvestri; Marcella Masciullo; Maria Piane; Camilla Savio; Anna Modoni; Massimo Santoro; Luciana Chessa
Journal:  J Neurol       Date:  2010-05-18       Impact factor: 4.849

3.  Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia.

Authors:  Kotoka Nakamura; Liutao Du; Rashmi Tunuguntla; Francesca Fike; Simona Cavalieri; Tomohiro Morio; Shuki Mizutani; Alfredo Brusco; Richard A Gatti
Journal:  Hum Mutat       Date:  2011-11-09       Impact factor: 4.878

4.  Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites.

Authors:  R Saunders-Pullman; D Raymond; A J Stoessl; D Hobson; K Nakamura; T Nakamura; S Pullman; D Lefton; M S Okun; R Uitti; R Sachdev; K Stanley; M San Luciano; J Hagenah; R Gatti; L J Ozelius; S B Bressman
Journal:  Neurology       Date:  2012-02-15       Impact factor: 9.910

5.  Rapid flow cytometry-based structural maintenance of chromosomes 1 (SMC1) phosphorylation assay for identification of ataxia-telangiectasia homozygotes and heterozygotes.

Authors:  Shareef A Nahas; Anthony W Butch; Liutao Du; Richard A Gatti
Journal:  Clin Chem       Date:  2009-01-15       Impact factor: 8.327

6.  ATM is down-regulated by N-Myc-regulated microRNA-421.

Authors:  Hailiang Hu; Liutao Du; Gindy Nagabayashi; Robert C Seeger; Richard A Gatti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

7.  The combined status of ATM and p53 link tumor development with therapeutic response.

Authors:  Hai Jiang; H Christian Reinhardt; Jirina Bartkova; Johanna Tommiska; Carl Blomqvist; Heli Nevanlinna; Jiri Bartek; Michael B Yaffe; Michael T Hemann
Journal:  Genes Dev       Date:  2009-07-16       Impact factor: 11.361

8.  Screening of CYP1B1 and MYOC in Moroccan families with primary congenital glaucoma: three novel mutations in CYP1B1.

Authors:  Latifa Hilal; Soraya Boutayeb; Aziza Serrou; Loubna Refass-Buret; Hafsa Shisseh; Fatiha Bencherifa; Mohammed El Mzibri; Bouchra Benazzouz; Amina Berraho
Journal:  Mol Vis       Date:  2010-07-02       Impact factor: 2.367

9.  Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.

Authors:  Sean V Tavtigian; Peter J Oefner; Davit Babikyan; Anne Hartmann; Sue Healey; Florence Le Calvez-Kelm; Fabienne Lesueur; Graham B Byrnes; Shu-Chun Chuang; Nathalie Forey; Corinna Feuchtinger; Lydie Gioia; Janet Hall; Mia Hashibe; Barbara Herte; Sandrine McKay-Chopin; Alun Thomas; Maxime P Vallée; Catherine Voegele; Penelope M Webb; David C Whiteman; Suleeporn Sangrajrang; John L Hopper; Melissa C Southey; Irene L Andrulis; Esther M John; Georgia Chenevix-Trench
Journal:  Am J Hum Genet       Date:  2009-09-24       Impact factor: 11.025

10.  Childhood-onset autosomal recessive ataxias: a cross-sectional study from Turkey.

Authors:  Hatice Mutlu-Albayrak; Emre Kırat; Gürkan Gürbüz
Journal:  Neurogenetics       Date:  2019-11-19       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.